Back to search

Helene Therapeutics Limited

15462784

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

GROUND FLOOR, LONDON, W1K 4HY
Incorporated 02/02/2024

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology
86220
Specialist medical practice activities
86900
Other human health activities

Officers

Mr Takaaki Matsuoka

director · Since 02/02/2024

DIRECTOR

JAPANESE · JAPAN · Age 49

Mrs Polytimi Ellina

director · Since 24/07/2024

SCIENTIST

GREEK · ENGLAND · Age 43

Also on 1 other board

Persons with Significant Control

Mr Takaaki Matsuoka

Significant control

Japanese · Japan · Age 49

3rd Floor, Aoyama-Ohmoto Bld, Tokyo, 107-0062

Notified 02/02/2024

CompanyRankvs 482+ SIC 72110 peers
73

Financial strength94th percentile among SIC peers · 24/25
Employees82th percentile among SIC peers · 12/15
LiquidityCurrent ratio 3.96× · 20/20
Longevity2 years trading (max 15) · 2/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity2/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 28/02/2025

Net Worth

£1.6M

Balance sheet strength

Cash

£1.8M

Cash in the bank

Net Current Assets

£1.8M

Working capital

Current Assets

£2.4M

Current Liabilities

£602k

Fixed Assets

£737k

Debtors

£604k

4avg. employees

Balance Sheet

Assets less current liabilities£2.5M
Signed by Mr Takaaki Matsuoka 5 November 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent Ratio
20253.96

Derived from filed accounts. Not audited figures.